K. Behnke

2.2k total citations
33 papers, 1.6k citations indexed

About

K. Behnke is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, K. Behnke has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 16 papers in Pharmacology and 11 papers in Experimental and Cognitive Psychology. Recurrent topics in K. Behnke's work include Treatment of Major Depression (16 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers) and Electroconvulsive Therapy Studies (7 papers). K. Behnke is often cited by papers focused on Treatment of Major Depression (16 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers) and Electroconvulsive Therapy Studies (7 papers). K. Behnke collaborates with scholars based in Denmark, Finland and United States. K. Behnke's co-authors include O.‐P. Mehtonen, J. Søgaard, W. Paska, John A. Ascher, Lakshmi N. Yatham, Gary Sachs, Charles L. Bowden, Paul Montgomery, Joseph DeVeaugh-Geiss and Nancy L. Earl and has published in prestigious journals such as The British Journal of Psychiatry, The Journal of Clinical Psychiatry and Acta Psychiatrica Scandinavica.

In The Last Decade

K. Behnke

33 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Behnke Denmark	19	983	620	480	334	130	33	1.6k
R R Fieve United States	26	1.1k 1.2×	413 0.7×	327 0.7×	456 1.4×	129 1.0×	63	1.8k
S. Hoog United States	12	857 0.9×	655 1.1×	464 1.0×	832 2.5×	104 0.8×	23	1.7k
Pierre V. Trân United States	17	1.5k 1.5×	616 1.0×	175 0.4×	297 0.9×	74 0.6×	28	1.9k
WFSBP Task Force on Treatment Guide United States	8	1.1k 1.1×	408 0.7×	190 0.4×	274 0.8×	110 0.8×	8	1.4k
U. G. Ahlfors Denmark	16	1.5k 1.5×	618 1.0×	274 0.6×	363 1.1×	139 1.1×	29	2.2k
G.D. Tollefson United States	17	1.1k 1.2×	455 0.7×	183 0.4×	442 1.3×	57 0.4×	76	1.6k
Steven K. Secunda United States	21	831 0.8×	289 0.5×	223 0.5×	221 0.7×	137 1.1×	33	1.2k
Anjana Bose United States	19	595 0.6×	931 1.5×	623 1.3×	256 0.8×	60 0.5×	28	1.5k
P.M.J. Haffmans Netherlands	20	455 0.5×	341 0.6×	359 0.7×	221 0.7×	65 0.5×	44	1.2k
S.H. Hamilton United States	18	2.4k 2.4×	725 1.2×	201 0.4×	483 1.4×	156 1.2×	41	3.0k

Countries citing papers authored by K. Behnke

Since Specialization

Citations

This map shows the geographic impact of K. Behnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Behnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Behnke more than expected).

Fields of papers citing papers by K. Behnke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Behnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Behnke. The network helps show where K. Behnke may publish in the future.

Co-authorship network of co-authors of K. Behnke

This figure shows the co-authorship network connecting the top 25 collaborators of K. Behnke. A scholar is included among the top collaborators of K. Behnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Behnke. K. Behnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allard, Per, et al.. (2004). Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopram. International Journal of Geriatric Psychiatry. 19(12). 1123–1130. 83 indexed citations

Bandelow, Borwin, et al.. (2004). Sertraline Versus Paroxetine in the Treatment of Panic Disorder. The Journal of Clinical Psychiatry. 65(3). 405–413. 34 indexed citations

Calabrese, Joseph R., Charles L. Bowden, Gary Sachs, et al.. (2003). A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder. The Journal of Clinical Psychiatry. 64(9). 1013–1024. 454 indexed citations

Behnke, K., J. Søgaard, S Martin, et al.. (2003). Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action Study. Journal of Clinical Psychopharmacology. 23(4). 358–364. 90 indexed citations

Behnke, K., et al.. (2002). Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Advances in Therapy. 19(1). 43–52. 62 indexed citations

Mehtonen, O.‐P., et al.. (2000). Randomized, Double-Blind Comparison of Venlafaxine and Sertraline in Outpatients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 61(2). 95–100. 82 indexed citations

Leìnonen, Esa, et al.. (2000). Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression. European Neuropsychopharmacology. 10. 265–265. 2 indexed citations

Tiller, John, et al.. (1999). Moclobemide and fluoxetine for panic disorder. European Archives of Psychiatry and Clinical Neuroscience. 249(S1). S7–S10. 36 indexed citations

Leìnonen, Esa, et al.. (1999). Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. International Clinical Psychopharmacology. 14(6). 329–337. 117 indexed citations

10.

Tiller, J. W. G., Colin Bouwer, & K. Behnke. (1997). Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.. PubMed. 12 Suppl 6. S27–30. 24 indexed citations

11.

Tiller, John, Colin Bouwer, & K. Behnke. (1997). Moclobemide for anxiety disorders. International Clinical Psychopharmacology. 12. S27–S27. 18 indexed citations

12.

Behnke, K., et al.. (1996). Paroxetine and amitriptyline in the treatment of depression in general practice. Acta Psychiatrica Scandinavica. 93(3). 158–163. 28 indexed citations

13.

Behnke, K., et al.. (1995). Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study. The British Journal of Psychiatry. 167(3). 374–379. 195 indexed citations

14.

Nielsen, Bjarne Mejer, et al.. (1993). A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder. Acta Psychiatrica Scandinavica. 87(4). 269–272. 26 indexed citations

15.

Behnke, K., et al.. (1991). [Violence by patients towards personnel/furniture in a psychiatric department. Patients' characteristics and reactions of the staff].. PubMed. 153(8). 571–3. 3 indexed citations

16.

Andersen, John Roger, Jens Knud Larsen, K. Behnke, et al.. (1989). The Brief Psychiatric Rating Scale. Psychopathology. 22(2-3). 168–176. 92 indexed citations

17.

Pedersen, Jonas N., et al.. (1988). An ethological analysis of depression: comparison between ethological recording and Hamilton rating of five endogenously depressed patients. Acta Psychiatrica Scandinavica. 78(3). 331–340. 11 indexed citations

18.

Pedersen, Jonas N., et al.. (1988). An ethological description of depression. Acta Psychiatrica Scandinavica. 78(3). 320–330. 23 indexed citations

19.

Larsen, Jens Knud, et al.. (1986). The Brief Psychiatric Rating Scale: Schizophrenia, Reliability and Validity Studies. Nordisk Psykiatrisk Tidsskrift. 40(2). 135–138. 25 indexed citations

20.

Gerlach, Jes, et al.. (1985). Sulpiride and Haloperidol in Schizophrenia: A Double-blind Cross-over Study of Therapeutic Effect, Side Effects and Plasma Concentrations. The British Journal of Psychiatry. 147(3). 283–288. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact